From January 12, 2024 to January 15, 2024, the company has repurchased 160,000 shares, representing 0.93% for ¥303.36 million. With this, the company has completed the repurchase of 160,000 shares, representing 0.93% for ¥303.36 million under the buyback announced on January 12, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,456 JPY | -3.27% | -1.84% | +28.92% |
04-12 | Daito Pharmaceutical Co.,Ltd. announces an Equity Buyback for 350,000 shares, representing 2.23% for ¥1,000 million. | CI |
04-12 | Daito Pharmaceutical Co.,Ltd. authorizes a Buyback Plan. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.92% | 251M | |
+21.09% | 43.27B | |
+25.28% | 22.92B | |
+19.22% | 15.43B | |
+13.51% | 12.95B | |
+44.01% | 11.83B | |
-7.79% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.02% | 5.55B |
- Stock Market
- Equities
- 4577 Stock
- News Daito Pharmaceutical Co.,Ltd.
- Tranche Update on Daito Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on January 12, 2024.